|
| long-acting Nalmefene (Nalmefene Consta 393.1 mg) (n = 1500) | extended-release Naltrexone (Vivitrol 380 mg) (n = 1500) |
| Age in years | 27.1 (±4.8) | 28.3 (±3.6) |
| Sex | No. (%) | No. (%) |
| Male | 1110 (74%) | 1080 (72%) |
| Female | 390 (26%) | 420 (28%) |
| Marital status | No. (%) | No. (%) |
| Never married | 765 (51%) | 780 (52%) |
| Married/de facto | 585 (39%) | 570 (38%) |
| Divorced/separated | 150 (10%) | 150 (10%) |
| Race | No. (%) | No. (%) |
| White | 663 (44.2%) | 691 (46.1%) |
| Asian | 256 (17.1%) | 335 (22.3%) |
| Black | 489 (32.6%) | 445 (29.7%) |
| Others | 92 (6.1%) | 29 (1.9%) |
| Employment status | No. (%) | No. (%) |
| Student | 210 (14%) | 285 (19%) |
| Employed (full/part time) | 795 (53%) | 750 (50%) |
| Unemployed/pension | 495 (33%) | 465 (31%) |
| Duration of opioid dependence in years | 9.1 (±4.5) | 10.0 (±3.9) |
| Distribution of Duration of Opiate Dependence | No. (%) | No. (%) |
| <5 years | 300 (20%) | 255 (17%) |
| 5 - 9 years | 360 (24%) | 315 (21%) |
| 10 - 14 years | 675 (45%) | 630 (42%) |
| >15 years | 165 (11%) | 300 (20%) |
| Opioid craving scale | 18 (±2) | 22 (±2) |
| Hepatitis C positive | 1170 (78%) | 1275 (85%) |
| Opiate used in 30 days prior to baseline assessment | No. (%) | No. (%) |
| Heroin | 1170 (78%) | 1155 (77%) |
| Methadone | 135 (9%) | 195 (13%) |
| Other opiates/analgesics | 195 (13%) | 150 (10%) |
| Injecting (intravenous) users | 930 (62%) | 915 (61%) |